Givaudan Spin-Off From Roche To Be Complete By May
This article was originally published in The Rose Sheet
Executive Summary
Roche plans to spin off its Givaudan Roure fragrances and flavors division to concentrate on core healthcare divisions, the company announced at an investor conference Dec. 6. The new entity will be independent by the end of May. Roche's board approved the plan Dec. 4.